Sponsor:
National Institute of Neurological Disorders and Stroke (NINDS)
Code:
NCT03678389
Conditions
Pituitary Neoplasm
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
ESC
Brief summary:
Conditions
Pituitary Neoplasm
Study ID
NCT03678389
Start date
May 9, 2019
Status verified date
Apr 20, 2026
Completion date
Dec 1, 2028
Anticipated
Primary completion date
Mar 1, 2028
Anticipated
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Enrollment
70 participants
Anticipated
Allocation
Non randomized
Intervention Model
Single group
Primary purpose
Device Feasibility
Arms
experimental: 1
Interventions
ESC
Primary outcome measure
Central contacts
Locations
National Institutes of Health Clinical Center
Recruiting
Bethesda, Maryland, United States, 20892
Contacts
For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR)
800-411-1222prpl@cc.nih.govSponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Last update posted
Sep 1, 2026
Last verified
Apr 20, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by National Institute of Neurological Disorders and Stroke (NINDS) on 2026-09-01.